- 2025-08-23 17:06Atopaxar 751475-53-3
- 2025-08-23 17:06Protease-Activated Receptor-2, amide (SLIGKV-NH2) 190383-13-2
- 2025-08-23 17:06Vorapaxar 618385-01-6
- 2025-08-23 17:05Vorapaxar sulfate 705260-08-8
- 2025-08-23 17:05Parstatin (mouse) 1065756-01-5
- 2025-08-23 17:05VKGILS-NH2 TFA 2828432-41-1
- 2025-08-23 17:05VKGILS-NH2 942413-05-0
- 2025-08-23 17:05TRAP-6 amide TFA 1426807-16-0
- 2025-08-23 17:05TFMU-ADPr triethylamine
- 2025-08-23 17:05TFLLRN-NH2 244095-36-1
- 2025-08-23 17:05tcY-NH2 TFA ((trans-Cinnamoyl)-YPGKF-NH2 TFA) 1262750-73-1
- 2025-08-23 17:05tcY-NH2 ((trans-Cinnamoyl)-YPGKF-NH2) 327177-34-4
- 2025-08-23 17:05SLIGRL-NH2 TFA (Protease-Activated Receptor-2 Activating Peptide TFA) 2828432-39-7
- 2025-08-23 17:04RAG8 peptide
- 2025-08-23 17:04Q94 hydrochloride 1052076-77-3
- 2025-08-23 17:04Protease-Activated Receptor-3 (PAR-3) (1-6), human TFA
- 2025-08-23 17:04Protease-Activated Receptor-3 (PAR-3) (1-6), human 1872435-09-0
- 2025-08-23 17:04Protease-Activated Receptor-1, PAR-1 Agonist TFA
- 2025-08-23 17:04Protease-Activated Receptor-1, PAR-1 Agonist 141136-85-8
- 2025-08-23 17:04pNP-ADPr disodium (ADP-ribose-pNP disodium)
